Immutep
IMMP
$2.25
Share price
2.27%
Change (1 day)
39.75%
Change (1 year)
Categories
Operating Margin for Immutep (IMMP)
Operating Margin at the end of 2022: -18,906.49%
According to Immutep's latest financial reports and stock price the company's current Operating Margin is -18,906.50%. At the end of 2022 the company had an Operating Margin of -18,906.49%.
Operating Margin history for Immutep from 2010 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -18,906.49% | |
| 2020 | -179.90% | -98.63% |
| 2019 | -13,123.28% | 2608.7% |
| 2018 | -484.49% | |
| 2016 | -36,101.39% | |
| 2012 | -1,311.89% | |
| 2010 | -2,321.62% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | -94.58% | -99.50% | 🇺🇸 USA |
 FibroGen FGEN | -266.12% | -98.59% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | -326.08% | -98.28% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.